ALEC Alector, Inc.

Nasdaq alector.com


$ 2.98 $ -0.05 (-1.64 %)    

Tuesday, 14-Oct-2025 15:59:56 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 2.99
$ 3.00
$ 2.75 x 25
$ 3.10 x 200
$ 2.87 - $ 3.07
$ 0.87 - $ 6.14
987,677
na
302.62M
$ 1.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-26-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-28-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-05-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 08-11-2020 06-30-2020 10-Q
22 05-13-2020 03-31-2020 10-Q
23 03-24-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-12-2019 06-30-2019 10-Q
26 05-13-2019 03-31-2019 10-Q
27 03-26-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 4-biotechnology-stocks-lead-momentum-gains-amid-strong-technicals

4 biotech stocks—ALDX, ALEC, BDTX, CHRS—show strong week-on-week momentum ranking gains and improving technical indicators.

 btig-reiterates-buy-on-alector-maintains-5-price-target

BTIG analyst Thomas Shrader reiterates Alector (NASDAQ: ALEC) with a Buy and maintains $5 price target.

 top-4-biotech-stocks-set-for-a-breakout-momentum-scores-surge

Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Ed...

 alector-raises-fy2025-sales-guidance-from-5000m-15000m-to-13000m-18000m-vs-12114m-est

Alector (NASDAQ:ALEC) raises FY2025 sales outlook from $5.000 million-$15.000 million to $13.000 million-$18.000 million vs $12...

 alector-q2-eps-030-beats-043-estimate-sales-7900m-beat-2750m-estimate

Alector (NASDAQ:ALEC) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.43) by 29...

 mizuho-upgrades-alector-to-outperform-raises-price-target-to-35

Mizuho analyst Graig Suvannavejh upgrades Alector (NASDAQ:ALEC) from Neutral to Outperform and raises the price target from ...

 alector-announces-neil-berkley-appointed-interim-chief-financial-officer-succeeding-marc-grasso-effective-june-20-2025

-- Neil Berkley, M.B.A., appointed Interim Chief Financial Officer, succeeding Marc Grasso, M.D., effective June 20, 2025 --SOU...

 hc-wainwright--co-maintains-buy-on-alector-raises-price-target-to-10

HC Wainwright & Co. analyst Andrew Fein maintains Alector (NASDAQ:ALEC) with a Buy and raises the price target from $7 t...

 alector-q1-eps-041-beats-048-estimate-sales-367m-miss-438m-estimate

Alector (NASDAQ:ALEC) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.48) by 14...

 morgan-stanley-assumes-alector-at-underweight-lowers-price-target-of-15

Morgan Stanley analyst Sean Laaman assumes Alector (NASDAQ:ALEC) with a Underweight rating and lowers Price Target of $1.5.

 hc-wainwright--co-reiterates-buy-on-alector-maintains-7-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates Alector (NASDAQ:ALEC) with a Buy and maintains $7 price target.

 alector-sees-fy2025-collaboration-revenue-to-be-between-5-million-and-15-million

Alector (NASDAQ:ALEC) sees FY2025 sales of $5.000 million-$15.000 million vs $62.89 million analyst estimate.

 alector-q4-2024-gaap-eps-002-up-from-049-yoy-sales-54240m-beat-16621m-estimate

Alector (NASDAQ:ALEC) reported quarterly losses of $(0.02) per share. This is a 95.92 percent increase over losses of $(0.49) p...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION